Nomura Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-38,092
| Closed | -$7M | – | 2450 |
|
|
2021
Q2 | $7M | Buy |
38,092
+25,608
| +205% | +$4.4M | 0.06% | 479 |
|
|
2021
Q1 | $1.91M | Sell |
12,484
-25,408
| -67% | -$3.93M | 0.01% | 882 |
|
|
2020
Q4 | $5.92M | Sell |
37,892
-630,688
| -94% | -$81M | 0.03% | 536 |
|
|
2020
Q3 | $76.5M | Buy |
668,580
+591,091
| +763% | +$63.8M | 0.45% | 84 |
|
|
2020
Q2 | $8.69M | Sell |
77,489
-3,468
| -4% | -$368K | 0.1% | 294 |
|
|
2020
Q1 | $7.27M | Sell |
80,957
-477,160
| -85% | -$46.8M | 0.1% | 288 |
|
|
2019
Q4 | $60.3M | Buy |
558,117
+547,852
| +5,337% | +$58.6M | 0.64% | 73 |
|
|
2019
Q3 | $1M | Buy |
10,265
+1,975
| +24% | +$223K | 0.01% | 839 |
|
|
2019
Q2 | $1.08M | Buy |
8,290
+2,690
| +48% | +$347K | 0.01% | 824 |
|
|
2019
Q1 | $758K | Buy |
+5,600
| New | +$696K | 0.01% | 855 |
|
|
2018
Q3 | – | Sell |
-4,030
| Closed | -$500K | – | 1605 |
|
|
2018
Q2 | $500K | Sell |
4,030
-13,468
| -77% | -$1.57M | ﹤0.01% | 1000 |
|
|
2018
Q1 | $1.95K | Sell |
17,498
-232,044
| -93% | -$27.7M | 0.01% | 856 |
|
|
2017
Q4 | $29.9M | Buy |
249,542
+122,100
| +96% | +$14.9M | 0.21% | 209 |
|
|
2017
Q3 | $17.9M | Sell |
127,442
-68,090
| -35% | -$9.25M | 0.17% | 259 |
|
|
2017
Q2 | $23.8M | Buy |
195,532
+177,288
| +972% | +$20.6M | 0.2% | 181 |
|
|
2017
Q1 | $2.21M | Sell |
18,244
-14,106
| -44% | -$1.82M | 0.03% | 652 |
|
|
2016
Q4 | $3.96M | Buy |
32,350
+28,423
| +724% | +$3.48M | 0.03% | 645 |
|
|
2016
Q3 | $482K | Sell |
3,927
-123,573
| -97% | -$15.9M | ﹤0.01% | 909 |
|
|
2016
Q2 | $15M | Buy |
127,500
+125,591
| +6,579% | +$17.8M | 0.24% | 217 |
|
|
2016
Q1 | $267K | Sell |
1,909
-1,491
| -44% | -$219K | 0.01% | 1106 |
|
|
2015
Q4 | $647K | Buy |
3,400
+1,342
| +65% | +$234K | 0.01% | 949 |
|
|
2015
Q3 | $323K | Sell |
2,058
-33,604
| -94% | -$6.13M | ﹤0.01% | 1151 |
|
|
2015
Q2 | $6.41M | Buy |
35,662
+18,791
| +111% | +$3.24M | 0.05% | 372 |
|
|
2015
Q1 | $2.93M | Sell |
16,871
-9,913
| -37% | -$1.79M | 0.03% | 527 |
|
|
2014
Q4 | $4.92M | Buy |
26,784
+5,940
| +28% | +$1.1M | 0.05% | 616 |
|
|
2014
Q3 | $3.45M | Buy |
20,844
+2,656
| +15% | +$436K | 0.03% | 850 |
|
|
2014
Q2 | $2.86M | Sell |
18,188
-34,314
| -65% | -$5.42M | 0.03% | 957 |
|
|
2014
Q1 | $8.01M | Buy |
52,502
+41,067
| +359% | +$6.53M | 0.06% | 556 |
|
|
2013
Q4 | $1.52M | Sell |
11,435
-26,297
| -70% | -$3.16M | 0.01% | 826 |
|
|
2013
Q3 | $4.37M | Buy |
37,732
+417
| +1% | +$45.8K | 0.04% | 524 |
|
|
2013
Q2 | $3.43M | Buy |
+37,315
| New | +$3.6M | 0.04% | 443 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM